Serum albumin (SA) accumulation by bronchogenic tumours: a tracer technique may help with patient selection for SA-delivered chemotherapy
- 1 September 1995
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 22 (9) , 989-996
- https://doi.org/10.1007/bf00808409
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Design of compounds having enhanced tumour uptake, using serum albumin as a carrier—part II. In vivo studiesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- Identification of tissue sites for increased albumin degradation in sarcoma-bearing miceJournal of Surgical Research, 1991
- Design of compounds having an enhanced tumour uptake, using serum albumin as a carrier. Part INuclear Medicine and Biology, 1989
- Characterization of in-vitro drug release and biological activity of methotrexate-bovine serum albumin conjugatesJournal of Pharmacy and Pharmacology, 1987
- Evolution of Acute Lymphoblastic Leukemia in Mice Treated with Carrier-Bound Methotrexate and LevamisoleChemotherapy, 1987
- The preparation and labeling of DTPA-coupled albuminThe International Journal of Applied Radiation and Isotopes, 1982
- Transferrin receptors and gallium-67 uptake in vitroEuropean Journal of Nuclear Medicine and Molecular Imaging, 1982
- Receptor-mediated endocytosis of alpha 2-macroglobulin in cultured fibroblasts.Journal of Histochemistry & Cytochemistry, 1980
- DISCUSSION PAPER: SOME BIOCHEMICAL AND PHARMACOLOGIC PROPERTIES OF AMETHOPTERIN-ALBUMINAnnals of the New York Academy of Sciences, 1971
- Protein utilization by cultured mammalian cells: The fate of guanidinated serum albuminExperimental Cell Research, 1966